Amy M.L. Quek

1.6k total citations
50 papers, 1.1k citations indexed

About

Amy M.L. Quek is a scholar working on Neurology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Amy M.L. Quek has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 10 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in Amy M.L. Quek's work include Mosquito-borne diseases and control (7 papers), Peripheral Neuropathies and Disorders (6 papers) and COVID-19 Clinical Research Studies (5 papers). Amy M.L. Quek is often cited by papers focused on Mosquito-borne diseases and control (7 papers), Peripheral Neuropathies and Disorders (6 papers) and COVID-19 Clinical Research Studies (5 papers). Amy M.L. Quek collaborates with scholars based in Singapore, United States and Australia. Amy M.L. Quek's co-authors include Raymond C.S. Seet, Erle C.H. Lim, Jetty Chung‐Yung Lee, Barry Halliwell, Wai Mun Loke, Yiong‐Huak Chan, Hui-Wen Huang, Shan Huang, Huansong Wang and Leonard L.L. Yeo and has published in prestigious journals such as Neurology, Diabetes Care and Free Radical Biology and Medicine.

In The Last Decade

Amy M.L. Quek

44 papers receiving 1.1k citations

Peers

Countries citing papers authored by Amy M.L. Quek

Since Specialization

Citations

This map shows the geographic impact of Amy M.L. Quek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy M.L. Quek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy M.L. Quek more than expected).

Fields of papers citing papers by Amy M.L. Quek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy M.L. Quek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy M.L. Quek. The network helps show where Amy M.L. Quek may publish in the future.

Co-authorship network of co-authors of Amy M.L. Quek

This figure shows the co-authorship network connecting the top 25 collaborators of Amy M.L. Quek. A scholar is included among the top collaborators of Amy M.L. Quek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy M.L. Quek. Amy M.L. Quek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shifts in asthma exacerbator profiles pre- and post-COVID-19: A retrospective study in Singapore 2025 ·Epidemiology ·G. H. C. Ng, Ming Ren Toh, Xiaoru Wen, Amy M.L. Quek, Shao Wei Lam, (unknown), Mariko Siyue Koh	0
2	Accelerated ageing predicts earlier onset of ischaemic stroke: a proteomic and transcriptomic investigation 2025 ·European Journal of Preventive Cardiology ·Amy M.L. Quek, (unknown), Tuan Zea Tan, (unknown), (unknown), (unknown), Mingxue Jing, (unknown), (unknown), (unknown), Hock Luen Teoh, V M Oh, (unknown), Raymond C.S. Seet	0
3	Efficacy of rituximab on antibody-positive small fiber neuropathy: A series of 5 cases 2025 ·Journal of Neuroimmunology ·Amanda Chan, (unknown), (unknown), (unknown), (unknown), Kay Wei Ping Ng, Amy M.L. Quek, Rahul Rathakrishnan, S. Thomas Ng, Herbert Schwarz, Anselm Mak, Vijay K. Sharma	1
4	Elevated uric acid and impaired triglyceride metabolism predict mortality in women after ischemic stroke 2025 ·Free Radical Biology and Medicine ·Amy M.L. Quek, (unknown), (unknown), (unknown), Tuan Zea Tan, (unknown), (unknown), (unknown), Barry Halliwell, Raymond C.S. Seet	2
5	Anti-IgLON5 Disease Presenting with Esophageal Achalasia and Hypercapnic Respiratory Failure 2024 ·The American Journal of Medicine ·(unknown), Yihui Goh, Hui Fang Lim, Yee Cheun Chan, Amy M.L. Quek	0
6	Biomarkers of early SARS-CoV-2 infection before the onset of respiratory symptoms 2023 ·Clinical Microbiology and Infection ·(unknown), Amy M.L. Quek, (unknown), Suqing Wang, (unknown), (unknown), (unknown), Paul Anantharajah Tambyah, Raymond C.S. Seet	3
7	Low incidence of neurological recurrent side-effects following COVID-19 reimmunization 2022 ·QJM ·Jasmine Shimin Koh, (unknown), (unknown), Yihui Goh, Benjamin Yong‐Qiang Tan, (unknown), Andrew Hui, Tian Ming Tu, (unknown), (unknown), Kevin Tan, Amy M.L. Quek, Thirugnanam Umapathi, Raymond C.S. Seet	5
8	COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD 2022 ·Multiple Sclerosis and Related Disorders ·Tianrong Yeo, Amy M.L. Quek, (unknown), (unknown), Pavanni Ratnagopal, Derek Soon, Kevin Tan	9
9	Estimating transmission dynamics of SARS-CoV-2 at different intraspatial levels in an institutional outbreak 2022 ·Epidemics ·(unknown), Borame Sue Lee Dickens, Amy M.L. Quek, Mikael Hartman, Paul Anantharajah Tambyah, Raymond C.S. Seet, Alex R. Cook	2
10	Autoimmune glial fibrillary acidic protein astrocytopathy masquerading as tuberculosis of the central nervous system: a case series 2022 ·International Journal of Infectious Diseases ·Amy M.L. Quek, David Tang, (unknown), (unknown), (unknown), Raymond C.S. Seet	14
11	Neuralgic amyotrophy following COVID-19 mRNA vaccination 2021 ·QJM ·Jasmine Shimin Koh, Yihui Goh, Benjamin Yong‐Qiang Tan, Andrew Hui, (unknown), Andrew Makmur, Pin Lin Kei, (unknown), Kay Wei Ping Ng, Amy M.L. Quek, (unknown)	15
12	Blood biomarkers to detect new-onset atrial fibrillation and cardioembolism in ischemic stroke patients 2021 ·Heart Rhythm ·Dorin Harpaz, Ram Bajpai, (unknown), Michael Soljak, Robert S. Marks, Christine Cheung, Thiruma V. Arumugam, Amy M.L. Quek, Alfred Iing Yoong Tok, Raymond C.S. Seet	11
13	Does High-Dose Coenzyme Q ₁₀ Improve Oxidative Damage and Clinical Outcomes in Parkinson's Disease? 2014 ·Antioxidants and Redox Signaling ·Raymond C.S. Seet, (unknown), (unknown), Amy M.L. Quek, (unknown), (unknown), (unknown), Choon Nam Ong, Barry Halliwell	30
14	Does Influenza A Infection Increase Oxidative Damage? 2014 ·Antioxidants and Redox Signaling ·(unknown), Jetty Chung‐Yung Lee, Wai Mun Loke, Leonard L.L. Yeo, Amy M.L. Quek, Erle C.H. Lim, Barry Halliwell, Raymond C.S. Seet	36
15	Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels 2011 ·Atherosclerosis ·Raymond C.S. Seet, Jetty Chung‐Yung Lee, Erle C.H. Lim, Amy M.L. Quek, Hui-Wen Huang, Shan Huang, (unknown), Lee Hua Long, Barry Halliwell	81
16	Biomarkers of oxidative damage in cigarette smokers: Which biomarkers might reflect acute versus chronic oxidative stress? 2011 ·Free Radical Biology and Medicine ·Raymond C.S. Seet, Jetty Chung‐Yung Lee, Wai Mun Loke, Shan Huang, Hui-Wen Huang, (unknown), (unknown), Amy M.L. Quek, Erle C.H. Lim, Barry Halliwell	126
17	Accurate targeting of botulinum toxin injections: How to and why 2011 ·Parkinsonism & Related Disorders ·Erle C.H. Lim, Amy M.L. Quek, Raymond C.S. Seet	22
18	Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case–control study 2009 ·International Journal of Infectious Diseases ·Raymond C.S. Seet, (unknown), Amy M.L. Quek, Yiong‐Huak Chan, Erle C.H. Lim	33
19	Post-infectious fatigue syndrome in dengue infection 2006 ·Journal of Clinical Virology ·Raymond C.S. Seet, Amy M.L. Quek, Erle C.H. Lim	110
20	Symptoms and risk factors of ocular complications following dengue infection 2006 ·Journal of Clinical Virology ·Raymond C.S. Seet, Amy M.L. Quek, Erle C.H. Lim	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact